Semglee® (interchangeable biosimilar insulin glargine) listed as a preferred insulin brand on National Preferred Formulary

Biocon announced that pharmacy benefit management company Express Scripts will list Semglee® (interchangeable biosimilar insulin glargine) as a preferred insulin brand on its National Preferred Formulary.